Orchid Pharma Board Meeting May 25 for FY26 Results

Orchid Pharma board meeting scheduled for May 25, 2026 to approve audited Q4 and FY26 financial results.
Trading window closed from April 1, 2026 until 48 hours after declaration of financial results.
Disclosure made under SEBI Listing Regulations Regulation 29 for prior intimation of board meeting.